Retinal Vein Occlusion (RVO)
6
1
1
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
16.7%
1 terminated out of 6 trials
0.0%
-86.6% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (6)
AI vs. Physician for Anti-VEGF Decision-Making: An RCT
Retinal Clinical Assessment With AI-derived Quantitative Information
Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment
High-throughput Large-model-based AI-assisted Diagnosis Using OCT
Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein Occlusion and Myopic Choroidal Neovascularisation Patients
Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF